vaccine manufacturing and clinical trial services for diarrheal disease product development rodolfo...
TRANSCRIPT
![Page 1: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/1.jpg)
Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease
Product Development
Rodolfo M. Alarcón, PhDEnteric and Hepatic Diseases Branch
Division of Microbiology and Infectious Diseases (DMID)
Enteric and Hepatic Diseases Branch
EHDB, NIAID, NIH, DHHS
Vaccines & Vaccination July 27-29, 2015
Brisbane, Queensland, Australia 1
![Page 2: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/2.jpg)
Overview
•Introduction to NIH/NIAID/DMID/EHDB– Organization and Mission– EHDB pathogen list and area of focus– EHDB PO contacts
•DMID grant, preclinical, and clinical support services•DMID clinical services
– EHDB Phase IV Rotavirus Vaccine Trial
![Page 3: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/3.jpg)
NIH Organization
27 IC’s (Institutes and Centers)Each with its own Goals, Programs, Approaches
http://www.nih.gov/icd/http://www.nih.gov/about/
National Institute of Allergy and Infectious Diseases (NIAID) — Est. 1948
NIAID research strives to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human
lives.
![Page 4: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/4.jpg)
How is NIH Organized?
• Director’s Office – sets policies, represents NIH to Congress, public, has modest discretionary $, etc.
• Institutes and Centers (I/C’s) – Each has focus, e.g., NCI, NIAID, NHBLI, NIDDK, etc.– Develop Specific Programs and Priorities– Intramural and Extramural
• Intramural conducts research • Extramural - Administer funding awards
• Center for Scientific Review (CSR) – special function to review grants via study sections (sometimes called Scientific Review Groups or SRG’s) directed by Scientific Review Officers (SRO’s).
![Page 5: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/5.jpg)
Office of the DirectorOffice of the Director
National Instituteon Alcohol Abuseand Alcoholism
National Instituteon Alcohol Abuseand Alcoholism
National Instituteof Arthritis andMusculoskeletal
and Skin Diseases
National Instituteof Arthritis andMusculoskeletal
and Skin Diseases
National CancerInstitute
National CancerInstitute
National Instituteof Diabetes andDigestive and
Kidney Diseases
National Instituteof Diabetes andDigestive and
Kidney Diseases
National Instituteof Dental andCraniofacial
Research
National Instituteof Dental andCraniofacial
Research
National Instituteon Drug Abuse
National Instituteon Drug Abuse
National Instituteof Environmental Health Sciences
National Instituteof Environmental Health Sciences
National Instituteon Aging
National Instituteon Aging
National Instituteof Child Health
and HumanDevelopment
National Instituteof Child Health
and HumanDevelopment
National Institute onDeafness and Other
CommunicationDisorders
National Institute onDeafness and Other
CommunicationDisorders
National EyeInstitute
National EyeInstitute
National HumanGenome Research
Institute
National HumanGenome Research
Institute
National Heart,Lung, and Blood
Institute
National Heart,Lung, and Blood
Institute
National Instituteof Mental Health
National Instituteof Mental Health
National Instituteof NeurologicalDisorders and
Stroke
National Instituteof NeurologicalDisorders and
Stroke
National Instituteof General
Medical Sciences
National Instituteof General
Medical Sciences
National Instituteof Nursing Research
National Instituteof Nursing Research
National Libraryof Medicine
National Libraryof Medicine
Center for InformationTechnology
Center for InformationTechnology
Center for Scientific Review
Center for Scientific Review
National Centerfor Complementary
and AlternativeMedicine
National Centerfor Complementary
and AlternativeMedicine
National Instituteof Allergy and
Infectious Diseases
National Instituteof Allergy and
Infectious Diseases
National Centerfor ResearchResources
National Centerfor ResearchResources
Clinical Center
Clinical Center
National Center on Minority Health andHealth Disparities
National Center on Minority Health andHealth Disparities
National Institute of Biomedical Imagingand Bioengineering
National Institute of Biomedical Imagingand Bioengineering
FogartyInternational
Center
FogartyInternational
Center
National Institutes of HealthNational Institutes of Health
PeerReview
![Page 6: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/6.jpg)
Extramural Research Staff
Program Staff• Responsible for the programmatic, scientific, and/or technical
aspects of a grant
Review Staff•Responsible to NIH for scientific and technical review of applications • Center for Scientific Review (CSR)• Regular and Ad Hoc Study Sections
Grants Management Staff• Responsible for ensuring that all required business management
actions are performed by the grantee and the federal government in a timely and appropriate manner both prior to and after award.
![Page 7: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/7.jpg)
Overall NIH Budget
Grants and Contracts
Intramural
![Page 8: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/8.jpg)
NIAID: Find us on the web
http://www.niaid.nih.gov
![Page 9: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/9.jpg)
Credit: AS Fauci
NIAID Research: A Dual Mandate
![Page 10: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/10.jpg)
Division of Microbiology and Infectious Diseases
Respiratory Diseases Branch
Office of Biodefense
Research Affairs
Office of Regulatory
Affairs
Office of Scientific
Coordination and Program
Operations
International Research in Infectious Diseases
Sexually Transmitted
Infections BranchVirology Branch
Enteric and Hepatic Diseases
Branch
Parasitology andInternational
Programs Branch
Bacteriology andMycology Branch
Office of the Director
Office of Genomics
and Advanced Technologies
Office of Clinical Research
Affairs
Office of Clinical Research Resources
Clinical Research Coordination
NIH/NIAID
![Page 11: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/11.jpg)
ENTERIC AND HEPATIC DISEASES BRANCH
Fred CasselsBranch Chief
Christian GonzalezProduct Manager
Shahida Baqar: E. coli, Stx,
ricin, Bacterioides
Robert Hall: Vibrio, Aeromonas
Bill Alexander:Salmonella, Yersinia
Melody Mills: Helicobacter, Listeria, Shigella, normal flora
Ryan Ranallo:Clostridia spp.,
Campylobacter, SEB
HEPATIC
Rajen Koshy: HCV, HBV, HAV,
HEV, HDV
CLINICAL
TBDClinical Project Mgr
Gabi Feolo Clinical Project Mgr
Robert Hall: Enterics,
Hepatic, toxins
ENTERIC DIAGNOSTIC
Rodolfo Alarcon: Enteric Viruses – NoV, RV
Product Development
Susan PayneHealth Specialist
TBDAdmin
Rahsan ErdemMedical Officer
![Page 12: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/12.jpg)
Find your POhttp://www.niaid.nih.gov/about/findingpeople/dmid/Pages/ehdb.aspx
![Page 13: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/13.jpg)
Credit: WHO
Diarrheal Disease
• Diarrheal disease is the second leading cause of death in children under five years old.
• It is both preventable and treatable.
• Each year diarrhea kills around 760,000 children under five.
• Diarrhea is a leading cause of malnutrition in children under five years old.
• A significant proportion of diarrheal disease can be prevented through safe drinking-water and adequate sanitation and hygiene.
• Globally, there are nearly 1.7 billion cases of diarrheal disease every year.
![Page 14: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/14.jpg)
Credit: WHO
Hepatitis
• Hepatitis viruses B and C cause acute and/or chronic infection and inflammation of the liver. • Major causes of severe illness and death.
• The global burden of disease due to acute hepatitis B and C and to cancer and cirrhosis of the liver is high (about 2.7% of all deaths) • Forecast to become a higher ranked cause of death
over the next two decades. • 57% of cases of liver cirrhosis and 78% of cases of
primary liver cancer result from hepatitis B or C virus infection.
![Page 15: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/15.jpg)
Credit: WHO
Hepatitis
• An estimated two billion people worldwide have been infected with hepatitis B virus
• 360 million have chronic (long-term) liver infections. • 620 000 people die every year as a result of hepatitis B virus
infection. • A vaccine against hepatitis B has been available since 1982.• Some 150 million people are chronically infected with hepatitis C virus• 350,000 people are estimated to die from hepatitis C-related liver
diseases each year.• Vaccination is one of the strategies used to prevent hepatitis infection.
• Vaccines exist against hepatitis A and B. • Effective candidate vaccines for hepatitis E prevention exist. • Progress has been shown in developing candidate vaccines against hepatitis C
![Page 16: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/16.jpg)
Research Steps in Vaccine Development15
– 2
0 y
ears
or m
ore
Credit: AS Fauci
Discovery and Product
Development Research
![Page 17: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/17.jpg)
How does the NIH support Vaccine Development?
Credit: AS Fauci
![Page 18: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/18.jpg)
DiscoveryTarget ID & Validation
Preclinical Development
Clinical Development
Vaccine
Resource CentersClinical Trial
Support: VTEU, other Mechanisms
STTR/SBIR, STTR/SBIR-AT-NIAID
R01, R21, R03 R34/U01
Contract Resources
Partnerships
NIAID Support Mechanisms Across the Product Development Pipeline
![Page 19: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/19.jpg)
Academia and Industry
• Peer-reviewed grants and contracts to public or private institutions and for-profit and non-profit organizations– Investigator-initiated grants
• Basic and Partnerships - R01, R21, R03• Clinical – R34/U01
– Targeted initiatives supporting both grants and contracts - PA, RFA, RFP, IAA, BAA
• Allows support for diverse research projectshttp://www.niaid.nih.gov/researchfunding/Pages/default.aspx
![Page 20: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/20.jpg)
http://www.niaid.nih.gov/LabsAndResources/resources/dmid/
DMID Resources for Researchers
![Page 21: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/21.jpg)
Animal Models of Infectious Diseases
• Provision of a broad range of in vivo models (small animal, non-human primate, and non-traditional models)
• Development of novel models
• Refinement of existing models
• Screening of products and efficacy testing to support FDA submissions
![Page 22: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/22.jpg)
Vaccine Manufacturing Services
•Training and Workshops•Feasibility, Gap Analysis, and Product Development Plan Support•Process Development Including Assay Development for •Product Release•Pilot/GLP and cGMP Manufacture•Audits
Includes vaccines, other biologics, challenge material, antigen enhancing substances, and delivery systems.
![Page 23: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/23.jpg)
Assay Development: Examples
• ELISA– Serum responses– IgG subclass– Avidity/ELISA
• Cytokine– mRNA levels (qRT-PCR)– ELISAs– Intracellular staining– Quantitation Luminex
• Functional– Toxin neutralizing– Microneutralization– Opsonophagocytic /
bactericidal
• Flow Cytometry– T-Cell proliferation– Cell viability
• Additional– Memory B cell ELISpot– Affymetrix Gene Chip– Immunohistochemistry– Viral plaque assay– TCID50
![Page 24: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/24.jpg)
Evaluation and Testing Services
• Assay Development– Measure humoral and cell mediated responses– Broad range of assays
• Immunogenicity and efficacy testing– GLP and non-GLP studies– Pivotal efficacy studies under the animal rule
• Clinical and Non-clinical sample testing– Support phase I-III
• Safety and toxicology studies– Tissue cross-reactivity– Biodistribution
![Page 25: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/25.jpg)
Reagent Repository: BEI Research Resources
• Provide reagents and resources for biodefense and emerging infections agents to the scientific community for use in basic and applied research– Academic, industry
scientists– Global access– “Free” (shipping costs)
www.beiresources.orgwww.beiresources.org
![Page 26: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/26.jpg)
http://www.niaid.nih.gov
NIAID Resources for Researchers
![Page 27: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/27.jpg)
NIAID Resources for Researchers
http://www.niaid.nih.gov/labsandresources/resources/
![Page 28: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/28.jpg)
NIH’s Network of Vaccine and Treatment Evaluation Units (VTEUs)
Established in 1962 Clinical trials to
evaluate vaccines, diagnostics and therapeutics
Epidemiologic studies Access to healthy and
sick populations Pediatric Adult Elderly
Domestic and international capabilities
![Page 29: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/29.jpg)
Summary
• NIAID/DMID/EHDB is assisting many investigators through
grants and preclinical services
• EHDB has conducted preclinical services and multiple
clinical trials for multiple investigators
• Program Officers are subject matter experts and entry point
for services
• Get to know your program officer (funded or not)
• Website: www.niaid.nih.gov
• Contact: [email protected]
![Page 30: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/30.jpg)
Direct NIAID Contributions to Selected FDA-Licensed Vaccines, 1994 - 2015
Credit: AS Fauci
![Page 31: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/31.jpg)
Credit: AS Fauci
Selected Infectious Diseases of Global Public Health Importance
![Page 32: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/32.jpg)
DMID Partnerships: Two Mechanisms
R21/R33 R01
![Page 33: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/33.jpg)
NIAID Small Business Innovation Research/Small Business Technology
Transfer Programs
• Standard SBIR and STTR solicitations
(PA-11-096; PA-11-097), US companies
• NIAID Advanced Technology Programs
(PA-10-123; PA-10-124)
• Phase II Competing Continuation
![Page 34: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/34.jpg)
NIAID Small Business Innovation Research/Small Business Technology
Transfer Programs
• Vaccine development for tuberculosis, STIs, hepatitis B and C, and malaria and other high-impact global parasitic diseases.
• Therapeutics for tuberculosis, hepatitis B and C, and malaria and other high-impact global parasitic diseases.
• Therapeutic enhancement and formulation technologies with the goal of improving drug development timeframes, productivity, efficacy, specificity, safety, stability, and delivery.
http://www.niaid.nih.gov/researchfunding/sb/Pages/default.aspx
![Page 35: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/35.jpg)
Phase IV Rotavirus Vaccine Trial (VTEU)
Vaccination Schedule by Study Group
Subject Age at
Vaccination
Group 1
243 infants
Group 2
243 infants
Group 3
243 infants
Group 4
328 infants
Group 5
328 infants
2 monthsRotaTeq® RotaTeq® RotaTeq® Rotarix® Rotarix®
4 months RotaTeq® Rotarix® RotaTeq® Rotarix® RotaTeq®
6 months RotaTeq® Rotarix® Rotarix® N/A RotaTeq®
Note: The minimum age at first vaccination is 6 weeks, and the maximum age at first vaccination is 14 weeks, 6 days. The minimum interval between doses is 4 weeks. The maximum age for the last vaccination is 8 months.
ClinicalTrials.gov A service of the U.S. National Institutes of Health
NCT 01266850
![Page 36: Vaccine Manufacturing and Clinical Trial Services for Diarrheal Disease Product Development Rodolfo M. Alarcón, PhD Enteric and Hepatic Diseases Branch](https://reader035.vdocument.in/reader035/viewer/2022062421/56649e615503460f94b5d0e1/html5/thumbnails/36.jpg)
Phase IV RV Vaccine Trial EnrollmentTwelve VTEU sites and subsites involved and reporting100% enrolled (04/08/13), 2 year completion